BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29027595)

  • 1. Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
    Peters V; Zschocke J; Schmitt CP
    J Inherit Metab Dis; 2018 Jan; 41(1):39-47. PubMed ID: 29027595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Global Cndp1-Knock-Out Selectively Increases Renal Carnosine and Anserine Concentrations in an Age- and Gender-Specific Manner in Mice.
    Weigand T; Colbatzky F; Pfeffer T; Garbade SF; Klingbeil K; Colbatzky F; Becker M; Zemva J; Bulkescher R; Schürfeld R; Thiel C; Volk N; Reuss D; Hoffmann GF; Freichel M; Hecker M; Poth T; Fleming T; Poschet G; Schmitt CP; Peters V
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
    Everaert I; Taes Y; De Heer E; Baelde H; Zutinic A; Yard B; Sauerhöfer S; Vanhee L; Delanghe J; Aldini G; Derave W
    Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1537-44. PubMed ID: 22496410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carnosine, carnosinase and kidney diseases].
    Kiliś-Pstrusińska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():215-21. PubMed ID: 22706107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
    Peters V; Schmitt CP; Zschocke J; Gross ML; Brismar K; Forsberg E
    Amino Acids; 2012 Jun; 42(6):2411-6. PubMed ID: 21833769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosine metabolism in diabetes is altered by reactive metabolites.
    Peters V; Lanthaler B; Amberger A; Fleming T; Forsberg E; Hecker M; Wagner AH; Yue WW; Hoffmann GF; Nawroth P; Zschocke J; Schmitt CP
    Amino Acids; 2015 Nov; 47(11):2367-76. PubMed ID: 26081982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosine and Diabetic Nephropathy.
    Peters V; Yard B; Schmitt CP
    Curr Med Chem; 2020; 27(11):1801-1812. PubMed ID: 30914013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.
    Sauerhöfer S; Yuan G; Braun GS; Deinzer M; Neumaier M; Gretz N; Floege J; Kriz W; van der Woude F; Moeller MJ
    Diabetes; 2007 Oct; 56(10):2425-32. PubMed ID: 17601992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnosinase deficiency: a new variant with high residual activity.
    Fleisher LD; Rassin DK; Wisniewski K; Salwen HR
    Pediatr Res; 1980 Apr; 14(4 Pt 1):269-71. PubMed ID: 7375183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
    Janssen B; Hohenadel D; Brinkkoetter P; Peters V; Rind N; Fischer C; Rychlik I; Cerna M; Romzova M; de Heer E; Baelde H; Bakker SJ; Zirie M; Rondeau E; Mathieson P; Saleem MA; Meyer J; Köppel H; Sauerhoefer S; Bartram CR; Nawroth P; Hammes HP; Yard BA; Zschocke J; van der Woude FJ
    Diabetes; 2005 Aug; 54(8):2320-7. PubMed ID: 16046297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration.
    Peters V; Jansen EE; Jakobs C; Riedl E; Janssen B; Yard BA; Wedel J; Hoffmann GF; Zschocke J; Gotthardt D; Fischer C; Köppel H
    Clin Chim Acta; 2011 Jan; 412(3-4):263-7. PubMed ID: 20971102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNDP1 knockout in zebrafish alters the amino acid metabolism, restrains weight gain, but does not protect from diabetic complications.
    Schmöhl F; Peters V; Schmitt CP; Poschet G; Büttner M; Li X; Weigand T; Poth T; Volk N; Morgenstern J; Fleming T; Nawroth PP; Kroll J
    Cell Mol Life Sci; 2019 Nov; 76(22):4551-4568. PubMed ID: 31073745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
    Ahluwalia TS; Lindholm E; Groop LC
    Diabetologia; 2011 Sep; 54(9):2295-302. PubMed ID: 21573905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.
    Riedl E; Koeppel H; Brinkkoetter P; Sternik P; Steinbeisser H; Sauerhoefer S; Janssen B; van der Woude FJ; Yard BA
    Diabetes; 2007 Sep; 56(9):2410-3. PubMed ID: 17601991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CTG repeat polymorphism in carnosine dipeptidase 1 (
    Yadav AK; Sinha N; Kumar V; Bhansali A; Dutta P; Jha V
    Indian J Med Res; 2016 Jul; 144(1):32-37. PubMed ID: 27834323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity.
    Peters V; Kebbewar M; Jansen EW; Jakobs C; Riedl E; Koeppel H; Frey D; Adelmann K; Klingbeil K; Mack M; Hoffmann GF; Janssen B; Zschocke J; Yard BA
    Amino Acids; 2010 May; 38(5):1607-15. PubMed ID: 19915793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity.
    Qiu J; Hauske SJ; Zhang S; Rodriguez-Niño A; Albrecht T; Pastene DO; van den Born J; van Goor H; Ruf S; Kohlmann M; Teufel M; Krämer BK; Hammes HP; Peters V; Yard BA; Kannt A
    Amino Acids; 2019 Jan; 51(1):7-16. PubMed ID: 29922921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
    Freedman BI; Hicks PJ; Sale MM; Pierson ED; Langefeld CD; Rich SS; Xu J; McDonough C; Janssen B; Yard BA; van der Woude FJ; Bowden DW
    Nephrol Dial Transplant; 2007 Apr; 22(4):1131-5. PubMed ID: 17205963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum carnosinase deficiency: a non-disabling phenotype?
    Cohen M; Hartlage PL; Krawiecki N; Roesel RA; Carter AL; Hommes FA
    J Ment Defic Res; 1985 Dec; 29 ( Pt 4)():383-9. PubMed ID: 4093964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.